remarkable

breakthrough-therapy-for-dravet-syndrome-shows-remarkable-efficacy-and-safety-offering-new-hope-for-children-with-severe-epilepsy

Breakthrough Therapy for Dravet Syndrome Shows Remarkable Efficacy and Safety, Offering New Hope for Children with Severe Epilepsy

Nila Kartika Wati July 11, 2026

An experimental gene-targeted therapy, zorevunersen, has demonstrated promising results in an international clinical trial,...

the-legacy-of-shaker-innovation-and-the-remarkable-inventions-of-sister-tabitha-babbitt

The Legacy of Shaker Innovation and the Remarkable Inventions of Sister Tabitha Babbitt

Dzikria Novita July 6, 2026

The history of American industrialization is often told through the lens of urban factories...

experimental-therapy-for-severe-childhood-epilepsy-shows-remarkable-safety-and-efficacy-in-reducing-seizures-and-improving-quality-of-life

Experimental Therapy for Severe Childhood Epilepsy Shows Remarkable Safety and Efficacy in Reducing Seizures and Improving Quality of Life

Nila Kartika Wati May 31, 2026

An international clinical trial, spearheaded by leading researchers at University College London (UCL) and...

experimental-therapy-for-severe-childhood-epilepsy-shows-remarkable-safety-and-efficacy-offering-new-hope-for-dravet-syndrome-patients

Experimental Therapy for Severe Childhood Epilepsy Shows Remarkable Safety and Efficacy, Offering New Hope for Dravet Syndrome Patients.

Nila Kartika Wati May 24, 2026

Results from a groundbreaking international clinical trial, spearheaded by University College London (UCL) and...

an-experimental-gene-targeted-therapy-for-dravet-syndrome-shows-remarkable-safety-and-efficacy-in-pioneering-clinical-trial

An Experimental Gene-Targeted Therapy for Dravet Syndrome Shows Remarkable Safety and Efficacy in Pioneering Clinical Trial

Nila Kartika Wati March 26, 2026

An investigational therapy, zorevunersen, designed to address the underlying genetic cause of Dravet syndrome,...